ERBB2 and breast carcinoma: In 2000, Perou et al.2 first proposed the concept of molecular classification based on gene expression profiling, which divided breast cancer into luminal (including luminal A and luminal B), HER2-positive (HER2+), basal-like, and normal-like subtypes.